NAMPT and B-cell chronic lymphocytic leukemia: However, in chronic lymphocytic leukemia (CLL), visfatin promoted CLL monocyte differentiation towards M2 phenotype [35,36], and is involved in human monocytic cell THP-1 differentiation via PMA pretreatment [37].